Ultrasensitive confocal fluorescence microscopy of C-reactive protein interacting with FcγRIIa

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 24, Issue 12, 2004, Pages 2372-2377

  Manolov, Dimitar E ^a   Röcker, Carlheinz ^a   Hombach, Vinzenz ^a   Nienhaus, G Ulrich ^a,b   Torzewski, Jan ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Atherosclerosis; Inflammation; Receptors; Ultrasensitive fluorescence microscopy

Indexed keywords

C REACTIVE PROTEIN; FC GAMMA RECEPTOR IIA; FC RECEPTOR; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY LABELING; ARTICLE; CARDIOVASCULAR DISEASE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISSOCIATION CONSTANT; FLUORESCENCE MICROSCOPY; LABORATORY TEST; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING;

ANIMALS; ANTIGENS, CD; BINDING SITES, ANTIBODY; C-REACTIVE PROTEIN; CERCOPITHECUS AETHIOPS; COS CELLS; FLOW CYTOMETRY; FLUORESCENT DYES; KINETICS; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; PROTEIN BINDING; RECEPTORS, IGG;

EID: 10644234880     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000147407.17137.02     Document Type: Article

References (33)

1. Mortensen RF. C-Reactive protein, inflammation, and innate immunity. Immunol Res. 2001;24:163-176.
2. Pepys MB, Hirschfield GM. C-Reactive protein: a critical update. J Clin Invest. 2003;111:1805-1812.
3. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-Reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836-843.
4. Torzewski J, Torzewski M, Bowyer DE, Frohlich M, Koenig W, Waltenberger J, Fitzsimmons C, Hombach V. C-Reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol. 1998;18:1386-1392.
5. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000;102:2165-2168.
6. Torzewski M, Rist C, Mortensen RF, Zwaka TP, Bienek M, Waltenberger J, Koenig W, Schmitz G, Hombach V, Torzewski J. C-Reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol. 2000;20:2094-2099.
7. Pasceri V, Cheng JS, Willerson JT, Yeh ET, Chang J. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation. 2001;103:2531-2534.
8. Zwaka TP, Hombach V, Torzewski J. C-Reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation. 2001;103:1194-1197.
9. Wang CH, Li SH, Weisel RD, Fedak PW, Dumont AS, Szmitko P, Li RK, Mickle DA, Verma S. C-Reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation. 2003;107:1783-1790.
10. Yeh ET, Willerson JT. Coming of age of C-reactive protein: using inflammation markers in cardiology. Circulation. 2003;107:370-371.
11. Verma S, Li SH, Badiwala MV, Weisel RD, Fedak PW, Li RK, Dhillon B, Mickle DA. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation. 2002;105:1890-1896.
12. Paul A, Ko KW, Li L, Yechoor V, McCrory MA, Szalai AJ, Chan L. C-Reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2004;109:647-655.
13. Volanakis JE, Wirtz KW. Interaction of C-reactive protein with artificial phosphatidylcholine bilayers. Nature. 1979;281:155-157.
14. de Beer FC, Soutar AK, Baltz ML, Trayner IM, Feinstein A, Pepys MB. Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein. J Exp Med. 1982;156:230-242.
15. Chang MK, Binder CJ, Torzewski M, Witztum JL. C-Reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids. Proc Natl Acad Sci U S A. 2002;99:13043-13048.
16. Volanakis JE. Complement activation by C-reactive protein complexes. Ann N Y Acad Sci. 1982;389:235-250.
17. Tebo JM, Mortensen RF. Characterization and isolation of a C-reactive protein receptor from the human monocytic cell line U-937. J Immunol. 1990;144:231-238.
18. Bharadwaj D, Stein MP, Volzer M, Mold C, Du Clos TW. The major receptor for C-reactive protein on leukocytes is fcγ receptor II. J Exp Med. 1999;190:585-590.
19. Stein MP, Edberg JC, Kimberly RP, Mangan EK, Bharadwaj D, Mold C, Du Clos TW. C-Reactive protein binding to FcγRIIa on human monocytes and neutrophils is allele-specific. J Clin Invest. 2000;105:369-376.
20. Chi M, Tridandapani S, Zhong W, Coggeshall KM, Mortensen RF. C-Reactive protein induces signaling through Fc γ RIIa on HL-60 granulocytes. J Immunol. 2002;168:1413-1418.
21. Stein MP, Mold C, Du Clos TW. C-Reactive protein binding to murine leukocytes requires Fc γ receptors. J Immunol. 2000;164:1514-1520.
22. Saeland E, van Royen A, Hendriksen K, Vile-Weekhout H, Rijkers GT, Sanders LA, van de Winkel JG. Human C-reactive protein does not bind to FcγRIIa on phagocytic cells. J Clin Invest. 2001;107:641-643.
23. Hundt M, Zielinska-Skowronek M, Schmidt RE. Lack of specific receptors for C-reactive protein on white blood cells. Eur J Immunol. 2001;31:3475-3483.
24. Wiedenmann J, Schenk A, Röcker C, Girod A, Spindler KD, Nienhaus GU. A far-red fluorescent protein with fast maturation and reduced oligomerization tendency from Entacmaea quadricolor (Anthozoa, Actinaria). Proc Natl Acad Sci U S A. 2002;99:11646-11651.
25. Schenk A, Ivanchenko S, Röcker C, Wiedenmann J, Nienhaus GU. Photodynamics of red fluorescent proteins studied by fluorescence correlation spectroscopy. Biophys J. 2004;86:384-394.
26. Kim HD, Nienhaus GU, Ha T, Orr JW, Williamson JR, Chu S. Mg2+-dependent conformational change of RNA studied by fluorescence correlation and FRET on immobilized single molecules. Proc Natl Acad Sci U S A. 2002;99:4284-4289.
27. Ying SC, Gewurz H, Kinoshita CM, Potempa LA, Siegel JN. Identification and partial characterization of multiple native and neoantigenic epitopes of human C-reactive protein by using monoclonal antibodies. J Immunol. 1989;143:221-228.
28. Sambrook J, Russell DW. Molecular Cloning. Cold Spring Harbor, NY: CSHL Press; 2001.
29. Warmerdam PA, van de Winkel JG, Gosselin EJ, Capel PJ. Molecular basis for a polymorphism of human Fc γ receptor II (CD32). J Exp Med. 1990;172:19-25.
30. Sako Y, Yanagida T. Single-molecule visualization in cell biology. Nat Rev Mol Cell Biol. 2003;(suppl):SS1-SS5.
31. Lieto AM, Cush RC, Thompson NL. Ligand-receptor kinetics measured by total internal reflection with fluorescence correlation spectroscopy. Biophys J. 2003;85:3294-3302.
32. Daeron M. Fc receptor biology. Annu Rev Immunol. 1997;15:203-234.
33. Bodman-Smith KB, Melendez AJ, Campbell I, Harrison PT, Allen JM, Raynes JG. C-Reactive protein-mediated phagocytosis and phospholipase D signaling through the high-affinity receptor for immunoglobulin G (FcγRI). Immunology. 2002;107:252-260.